Current standard values of health utility scores for evaluating cost-effectiveness in liver disease: A meta-analysis

Table 6 Compensated liver cirrhosis vs sustained virologic response

Questionnare	Compensated LC	SVR	P value	% improvement
SF-36: Physical function	79.3 ± 19.3	83.9 ± 17.8	0.07	105.8
SF-36: Role physical	61.5 ± 31.6	73.3 ± 27.3	0.004	119.2
SF-36: Body pain	80.8 ± 23.1	85.4 ± 21.3	0.09	105.7
SF-36: General health	64.8 ± 20.9	74.8 ± 18.5	< 0.001	115.4
SF-36: Vitality	70.5 ± 24.0	78.1 ± 18.4	0.002	110.8
SF-36: Social function	77.0 ± 19.0	83.3 ± 15.6	0.05	108.2
SF-36: Role emotional	56.8 ± 32.0	68.1 ± 27.3	< 0.001	119.9
SF-36: Mental health	77.2 ± 16.8	81.3 ± 15.2	0.12	105.3
EQ-5D-5L	0.6863 ± 0.3065	0.846 ± 0.1816	< 0.001	123.3

LC: Liver cirrhosis; SVR: Sustained virologic response; SF-36: Short from-36; EQ-5D-5L: EuroQol 5-dimensions 5-levels.